Home / Company

About Micropos Medical

Micropos Medical AB (publ) is a Swedish medical device company founded in 2003 as a result of four oncology professors with a firm belief in real-time tumour tracking, to enable focused radiotherapy treatment to the tumour while saving healthy surrounding tissue.

What we do

Micropos Medical develops and provides technologies that enhance precision radiotherapy of cancer.

The first product, Raypilot system, is an electromagnetic positioning system that enables real-time information of the target localization. This provides a fast and objective set-up and continuous monitoring throughout treatment.

Raypilot HypoCath, the newest member of the Raypilot family, is designed like an ordinary urinary catheter with integrated Raypilot transmitter technology. It is an alternative requiring no surgical intervention with the same features as the original Raypilot. It will enhance clinical confidence when performing hypofractionated/SBRT prostate cancer treatment protocols for any linac system.

The Raypilot system together with Raypilot HypoCath are CE-certified for prostate use but have potential for future use in other tumor areas.

Our ambition is that Raypilot will enable more accurate treatment, reduce undesirable side effects, and achieve higher patient throughput, which benefits both patients and healthcare providers.

Micropos Medical AB (publ) is a company listed on the Swedish Spotlight Stock Market (formerly AktieTorget) under the stock ticker MPOS.

Meet the team


Thomas Lindström


Production Manager

Richard Nilsson


Director QA, Regulatory and Clinical Affairs

Hanna Syrén


R&D Manager

Andreas Bergqvist


R&D group - Service and Installation Manager

Oscar Sjöberg


Marketing and Communications - Marketing Manager

Jennie Söderberg


Sales Head Nordics

Richard Forsberg